Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma
Clinical trial NCT02573233 · COMPLETED
Trial details
- NCT number
- NCT02573233
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-27
- Primary completion
- 2018-01-03
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.